Revolution Medicines
Pay Change, last update 1 day ago
Pharma biotech · Headquarters United States
Everything we hold on Revolution Medicines, newest first. Every line links to the filing or report it came from.
- 2026-08-15Pay Change Pay and benefits
Revolution Medicines advertises a median posted salary band of $201,000 to $251,000 across 199 open roles
Advertised bands move before published pay data does, because they are set by what an employer thinks it must offer to fill a role today. Read the direction across postings rather than any one band, and remember this is the ask, not the settlement.
- 2026-08-11Adding Roles Growing and expanding
Revolution Medicines opened 23 more roles in Basel (job board: 267 to 290)
A board that grows week on week is the earliest public evidence of hiring intent an employer produces: it moves before any announcement and before any filing. Treat the direction as the signal and the exact count as approximate, since roles are reposted, split across locations and withdrawn without notice.
- 2026-06-22Headcount Not Stated Leadership moves
Revolution Medicines, Inc. 8-K filing: officer or director change
Revolution Medicines' president of research and development transitions to a senior advisor role ahead of retirement, with potential board appointment.
- 2025-12-31Pay Change Pay and benefits
REVOLUTION MEDICINES, INC.: $14,672,390 total compensation for the principal executive officer, fiscal year ended 2025-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
- 2024-12-31Pay Change Pay and benefits
REVOLUTION MEDICINES, INC.: $10,079,491 total compensation for the principal executive officer, fiscal year ended 2024-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
- 2023-12-31Pay Change Pay and benefits
REVOLUTION MEDICINES, INC.: $10,411,247 total compensation for the principal executive officer, fiscal year ended 2023-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
- 2022-12-31Pay Change Pay and benefits
REVOLUTION MEDICINES, INC.: $7,217,839 total compensation for the principal executive officer, fiscal year ended 2022-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
The read-through on each line is our interpretation. The headline and figures come from the linked source. Data licensed CC BY 4.0. Back to the tracker